SureTrader Nadex Advertisement SureTrader
Home > Boards > US OTC > Miscellaneous >

EP Global Communications, Inc. (EPGL)

Add EPGL Price Alert      Hide Sticky   Hide Intro
Moderator: Atlanta1, flaflyersfan, integral, Stock Barber, vikingzskillz, Hyd
Search This Board: 
Last Post: 4/25/2017 2:28:39 PM - Followers: 478 - Board type: Free - Posts Today: 11


People, Products & Process:
EPGL has assembled an impressive team to propel the company into a bright future and to build shareholder value. Under the leadership of Michael Hayes EPGL underwent debt restructuring, assembly of a new management team, as well as medical and scientific personnel. Mr. Hayes has made it a singular priority to bring aboard only the world’s top professionals in the field of medical sciences to EPGL and thereby build the Company into a major player in the Medical Device Industry over the next several years. He has also committed to prioritizing shareholders and creating significant value for their investment over time. We have seen great evidence of the har work over the last couple years as EPGL has signed Development Agreements with CooperVision, Intel, and AT&T. EPGL is in negotiations to licence technology to CooperVision presently. On April 28th 2015, EPGL disclosed to shareholders that
EPGL and AT&T have created joint Intellectual Properties and are now in the process of procuring those properties. Shareholders can expect developments on this in the near future.

One key team member that was brought on board is David Markus (Vice President, BioMEMS) Developer, As you will see David Markus is a Well Accomplished Engineer.

David T. Markus holds a Ph.D. in Biomedical Engineering and a MS in Electrical Engineering with an emphasis in MEMS Microelectronics and Biomedical. Dr. Markus spent 11 years with Raytheon and holds 8 US patents and has 9 other US Patents Pending. He has been involved in research for several of the world's leading technological institutions, including the Office of Naval Research in Arlington, Virginia, NASA Jet Propulsion Laboratory in Pasadena, CA and he has been published 15 times for various technical conferences. He was a principal investigator on SBIR DARPA Phase I and Phase II, and "Ultraflexible Substrate" for Macroelectronics Program by Dr. Robert Reuss at DARPA. He has been involved in the engineering and the development on seven surgical devices, including devices for Cataract surgery, Intra-Ocular Lens Delivery, Arthroscopy, Endodontic Endoscope, Micro Endoscope and Neural Electrodes. Additionally he was instrumental on developing three medical laboratory devices, including for In-Vitro Fertilization, PCR instrumentation and drug discovery.

The Company claims to have significant know-how and Intellectual Property in the arena of BioMEMS and claims to have invented new device technologies which include, but are not limited to the following:
1. Advanced Power Source for Contact Lenses 11. Advanced TopSpin Platform Technology for Development of Smart Medical Devices
2. Advanced Cell Regeneration Technology to Treat Eye Disease 12. Advanced Device for Steam Cell Treatment Delivery
3. Advanced Cell Regeneration Technology to Treat Hearing Loss 13. Advanced Device for Treatment of Prostate Tumors
4. Advanced Nerve Ablation Device 14. Advanced Endoscopic Device
5. Advanced Epidural Device 15. Advanced Device for Delievery of Micron Sized Drug Payloads
6. New & Promsing Treatment of Restinitis Pigmentosa 16. New & Promising Device for Treatment of Macular Degeneration
7. Advanced Ablation Device for Nerve Treatment of Facial Glabballar Frownig 17. New Advanced Contact Lens Device
8. New Advanced PowerSource for TopSpin Medical Devices 18. Advanced Device For Delivery of Micro Mechanical Devices Into Body
9. Advanced Trigger Point Needle Device 19.  Device for  Advanced Biopsy
10. Advanced Micron Resolution Motor for Smart Medical Devices 20. Real-Time Sensor Technologies for Connectivity to a Global Network  **NEW
21.Real-Time Data Applications for Athletic Teams, Workforces and Military Forces*NEW

About EPGL Medical Science's Share Structure :

EPGL has a share structure of 5 billion authorized shares with approximately 4.5 billion shares restricted and a float of approximately 499 million. Following a very successful Reverse Split EPGL has decreased the float by 90% and increased share holder value by over 500% since that time. The company has strongly stated many times that they will not sell shares into the retail market. They are here to build a real company and implement real growth. Since restructuring EPGL has not increased the Float/OS/AS and have given us there word on countless occasions they will not do so.

Pricewaterhouse Coopers, Corporate Finance and Recovery (Cayman) Ltd.Controlling Agent for:
AJW Qualified Partners, LLC, Controlled by PwC (PricewaterhouseCoopers) - Court appointed
1.975 Billion Common Shares
Mr. Michael Hayes
1.975 Billion Common Shares
FLOAT/TRADABLE SHARES : 499 Million ***Unchanged since Restructure in 2012***
Total number of shareholders of record 700 approximate 

The Company claims to have leases or utilizes facilities in the following locations

Various California Bay Area Research Facilities Under NDA, David T. Markus, Ph.D.

Irvine, California – Research Facilities, Office

New York University Langone Medical Center, Corey W. Hunter M.D. / Eric Lee M.D.

University of Minnesota, David T. Markus, Ph.D.

University of California at Irvine, David T. Markus, Ph.D.

Dallas and Plano Texas, David T. Markus, Ph.D. **NEW**

Follow EPGL on the WEB at



  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
#117812  Sticky Note Can't it be BOTH A and B? Me thinks Doubledown22 04/19/17 10:54:20 AM
#108787  Sticky Note EPGL Wins Allowance on First Patent vikingzskillz 08/30/16 10:08:17 PM
#95482  Sticky Note Press releases or other company communication should not IH Brian (Retired) 01/12/16 12:14:18 PM
#118062   So if EPGL is swallowed up by InWith, skorz 04/25/17 02:28:38 PM
#118061   Are you privy to the reports regarding everything? Atlanta1 04/25/17 02:27:20 PM
#118060   Have you spoken to these "Stoked" investors? Are skorz 04/25/17 02:25:29 PM
#118059   Nobody is selling because the price is crap. skorz 04/25/17 02:22:58 PM
#118058   The Investors PWC represents are stoked for what's H8ster 04/25/17 02:05:49 PM
#118055   False, when the buyout comes, Inwith will swallow franck92 04/25/17 01:20:31 PM
#118054   looking to merge into InWith and escape the Atlanta1 04/25/17 01:19:51 PM
#118053   This stinky pink EPGL with a CEO who skorz 04/25/17 01:16:08 PM
#118052   "Let's see, Patents in hand, more pending. Deals franck92 04/25/17 09:55:56 AM
#118051   Lol, they already are being held accountable for everything. H8ster 04/24/17 07:15:33 PM
#118047   EPGL will be the DMV of the 21st jhnvtjll 04/24/17 01:44:05 PM
#118045   Sorry Inwith is going to have the IP franck92 04/24/17 01:27:20 PM
#118044   Being there like that makes it look like Atlanta1 04/24/17 01:22:36 PM
#118043   I was bored and started really looking over CancunCharlie 04/24/17 01:20:42 PM
#118041   More than likely, we will see a walk rostam92 04/24/17 10:09:51 AM
#118039   $InWith/$EPGL /BLUECHIP in final negotiations to enable license franck92 04/24/17 12:57:21 AM
#118038   $InWith readies major $$$ capital raise. franck92 04/24/17 12:56:59 AM
#118037   Why Inwith ? franck92 04/24/17 12:41:47 AM
#118036   What I find interesting... and has been forgotten... Stock Barber 04/23/17 11:16:37 PM
#118035   Market Maker WDCO has the impact here. Remember 4u2nv2 04/23/17 11:08:37 PM
#118034   Let's hope it gets done!! :) gman22 04/23/17 08:26:55 PM
#118030   Yes a licensing agreement is the start of vikingzskillz 04/23/17 02:37:59 PM
#118029   Licensing deals, buyout, funds raised, Epgl technology is franck92 04/23/17 12:49:27 PM
#118028   "are few people with no impact" Stock Barber 04/23/17 12:35:37 PM
#118027   Sure, Coopervision R&D, JNJ first rights and maybe franck92 04/23/17 11:43:58 AM
#118026   gman22, hoping and praying are not good investment strategies; flaflyersfan 04/23/17 10:36:30 AM
#118025   I plead the fith rostam92 04/23/17 02:03:50 AM
#118024   I'm hopeful for some significant news in the gman22 04/22/17 10:17:42 PM
#118023   For the moment our right to have gifted Koog 04/22/17 06:52:16 PM
#118022   For the moment our right to have gifted franck92 04/22/17 12:37:32 PM
#118020   So, have you seen the "Gifted Inwith Shares". Hyd 04/22/17 11:32:31 AM
#118019   Simple. Inwith owned nothing.But it is changing now. franck92 04/22/17 09:56:26 AM
#118018   More carrot dangling tweets! Where the heck is Hyd 04/22/17 07:22:20 AM
#118017   Praying that EPGL gets some kind of licensing gman22 04/22/17 03:01:50 AM
#118015   Exactly...A while back someone who mentioned this stock rostam92 04/21/17 09:18:56 PM
#118014   I had 100k at the ask back then Badgerland 04/21/17 09:07:18 PM
#118013   $100! Lol! How much money did H8ster 04/21/17 09:03:17 PM
#118012   They can have 10 Blue Chip deals. They Badgerland 04/21/17 07:38:06 PM
#118010   The tweets have always left big gaps for Volcanridge 04/21/17 05:34:34 PM
#118009   Yep,I agree. Donguri 04/21/17 05:18:52 PM
#118008   We have seen many times Volcanridge 04/21/17 05:15:00 PM
#118006   WOW..up 21.62% for today! Donguri 04/21/17 04:23:30 PM
#118005   "So Inwith will have arguments to attract investors.." Donguri 04/21/17 04:15:07 PM
#118004   "in just days" maybe this concerns only the franck92 04/21/17 04:12:04 PM
#118001   I'll make a prediction... Stock Barber 04/21/17 03:35:35 PM
#117996  Restored so my horses need to calm down and Atlanta1 04/21/17 03:22:16 PM
#117995   Now please hold your horses..! Donguri 04/21/17 03:17:44 PM
#117994   Yep!! Still holding millions upon millions...never sold gman22 04/21/17 03:16:39 PM
#117993   wow - I guess that means I should Atlanta1 04/21/17 03:15:52 PM
#117992   Yep,I agree.My guess: Thursday,27th of April. Donguri 04/21/17 03:14:17 PM